| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.03. | Thermo Fisher Opens Bay Area Cryo-EM Drug Discovery Center | ||
| 06.03. | Nicoya Lifesciences Launches Mass Spectrometry Platform to Measure Protein Dynamics | ||
| 06.03. | Coating Place Updates Leadership and Launches New OSD Packaging Line | ||
| 06.03. | Forma Life Sciences Launches U.S. Based CDMO | ||
| 06.03. | Johnson & Johnson's TECVAYLI plus DARZALEX FASPRO Approved by FDA for RRMM | ||
| 05.03. | SmartSkin Technologies Introduces Seal Assurance Solution | ||
| 05.03. | Invivyd Names Michael Mina Chief Medical Officer | ||
| 05.03. | Frontage Labs Completes Acquisition of Teddy Lab | ||
| 05.03. | Novartis to Build New Radioligand Therapy Site in Denton, Texas | ||
| 05.03. | Arcutis Promotes Mas Matsuda to Executive Vice President, Chief Legal Officer | ||
| 05.03. | Upperton Seeks MHRA Approval for New Sterile Manufacturing Facility | ||
| 05.03. | Therna Biosciences, Charles River Partner to Advance Single-Patient RNA Medicines | ||
| 05.03. | XyloCor Therapeutics Names New President and CEO | ||
| 04.03. | Codis Expands Mfg. Capabilities for Commercial-Scale Amorphous Solid Dispersions | ||
| 04.03. | Fujifilm Biotechnologies Introduces ShunzymeX Precision Purification Technology | ||
| 04.03. | Teva, Blackstone Life Sciences Enter $400M Funding Agreement for Duvakitug | ||
| 04.03. | Codexis Agrees to Manufacture 50 Grams of siRNA Using its Proprietary Manufacturing Platform | ||
| 04.03. | CordenPharma Colorado Leases Space at Flatiron Park Campus | ||
| 04.03. | Glenmark Gets FDA Nod for Fluticasone Propionate Inhalation Generic | ||
| 04.03. | Sino Biopharm Licenses Rovadicitinib to Sanofi for up to $1.5B | ||
| 04.03. | Antheia Secures Additional Funding from HHS to Onshore Supply Chains | ||
| 04.03. | Hoth Therapeutics Deploys OpenAI API to Support Development of HT-KIT | ||
| 04.03. | Moderna Resolves Worldwide Arbutus/Genevant Litigation | ||
| 03.03. | Latigo Biotherapeutics Names Neha Krishnamohan CFO and CBO | ||
| 03.03. | Kivu Bioscience Appoints Brunilda Shtylla Chief Business Officer |